Explore evidence

70.8 %Among IgM-positive participants, 70.8% (34/48) had detectable HEV RNA.

Nigeriahepatitis E viruspublished 2026Journal of infection and public healthPubMeddocument of 9 observations

58.3 %Among respondents who would accept the HPV vaccine for their female adolescents, 58.3% cited prevention of HPV transmission as the commonest reason.

Nigeriainfection à HPVobserved 2023published 2025The Pan African medical journalPubMeddocument of 10 observations

89.7 %Out of 378 participants, 339 (89.7%) were using hydroxyurea while 39 (10.3%) had stopped using hydroxyurea at the time of the study.

Nigeriadrépanocytosepublished 2022Frontiers in geneticseurope_pmcdocument of 10 observations

73.6 %The tuberculosis-specific service readiness index was 73.6% in Anambra state.

Nigeriatuberculosepublished 2020BMC health services researchPubMeddocument of 14 observations

98.6 %Overall retention to care was 98.6%.

NigeriaVIH/sidaobserved May 2022 to May 2023published 2026BMC public healthPubMeddocument of 9 observations

268 cells_per_mm3The mean CD4 count at enrollment in care was 268 ± 23.7 cells per mm³.

NigeriaVIH/sidapublished 2020AIDS research and therapyPubMeddocument of 12 observations

55 %Among 108 children who completed the feasibility trial for managing severe acute malnutrition in older children with sickle cell anemia in Nigeria, 55% (n = 59) had low food security and 34% (n = 37) had very low food security.

Nigeriadrépanocytose · malnutritionpublished 2025Pediatric blood & cancerPubMeddocument of 4 observations

3.37 aorSpousal HIV-positive status was associated with improved HRQOL (adjusted odds ratio = 3.37, 95% confidence interval: 1.46–7.74).

NigeriaVIH/sidapublished 2020BMC public healthPubMeddocument of 11 observations

53 %Among asymptomatic malaria infections in adolescents in Ibadan, Plasmodium malariae accounted for 53% of cases.

Nigeriapaludismeobserved 2016published 2022International journal for parasitologyPubMeddocument of 14 observations

0.3 %State-level HIV prevalence in Nigeria ranged from 0.3% to 4.3% based on data from the Nigeria HIV/AIDS Indicator and Impact Survey (NAIIS) conducted from July to December 2018.

NigeriaVIH/sidaobserved 2018published 2022PloS onePubMeddocument of 5 observations

35.6 %Treatment with ciprofloxacin 160 mg kg-1 alone suppressed parasitaemia by 35.6%.

Nigeriapaludismepublished 2015Parasitologyeurope_pmcdocument of 9 observations

90 womenWe screened cervical samples from 90 women with possible HPV infections collected in two regional hospitals in Nigeria.

Nigeriainfection à HPVpublished 2023Virology journalPubMeddocument of 8 observations

27.6 %Asymptomatic malaria parasitaemia was observed in 27.6% of children under 5 years.

Nigeriapaludismepublished 2020West African journal of medicinePubMeddocument of 6 observations

40 %The proportion of viral non-suppressed participants among youth living with HIV in Nigeria was 40% at baseline.

NigeriaVIH/sidaobserved 2021published 2025AIDS and behaviorPubMeddocument of 2 observations

2.7 %The prevalence of Metabolic Syndrome among normal-weight adolescents in Mushin Local Government, Lagos was 2.7%.

Nigeriasyndrome métaboliquepublished 2024West African journal of medicinePubMeddocument of 5 observations

1.9 %Women aged 15 to 49 years in Nigeria have an HIV prevalence rate of 1.9%.

NigeriaVIH/sidapublished 2022The Pan African medical journalPubMeddocument of 2 observations

500,000 peopleBased on NAIIS results, funds were provided to place an additional 500,000 HIV-positive Nigerians on antiretroviral therapy by the end of 2020.

NigeriaVIH/sidaobserved 2020published 2021Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 6 observations

11 %Anti-HDV antibody seroprevalence was 11.0% among individuals with hepatocellular carcinoma (HCC) and/or cirrhosis in Nigeria.

Nigeriahepatitis D viruspublished 2026BMC infectious diseasesPubMeddocument of 7 observations

0.4 mmol/LMedian serum magnesium levels were significantly lower in patients with type 2 diabetes mellitus than in controls: 0.40 mmol/L (interquartile range 0.30–0.43) versus 0.88 mmol/L (interquartile range 0.76–1.02).

Nigeriadiabète de type 2PubMeddocument of 7 observations

85 %Eighty five percent (71/84) of the Plasmodium falciparum isolates were resistant in-vitro to chloroquine.

Nigeriapaludismepublished 2008The open tropical medicine journaleurope_pmcdocument of 7 observations

88 %At the 10% threshold, 88% of the poorest quartile of sickle cell disease patients experienced catastrophic expenditure.

Nigeriadrépanocytosepublished 2022PloS onePubMeddocument of 5 observations

43 %43% of the respondents cited lack of a doctor's request as the most common reason for not having undergone cervical screening.

Nigeriacancer du col de l'utéruspublished 2024African health sciencesPubMeddocument of 5 observations

0.5 %The prevalence of HIV in the study population was 0.5%.

NigeriaVIH/sidapublished 2025American journal of clinical pathologyPubMeddocument of 5 observations

6 %Only 6% of women had HIV tests during labour.

NigeriaVIH/sidaobserved 2013published 2020Journal of biosocial sciencePubMeddocument of 4 observations

0.316 rhoThere was a significant correlation between knowledge and practice of HIV PEP among doctors (Spearman's rho = 0.316, p < 0.05).

NigeriaVIH/sidapublished 2020West African journal of medicinePubMeddocument of 6 observations